6550--Base | EPOC/RapidPoint Blood Gas

The contract, identified by solicitation number 36C26226Q0673, is a Firm-Fixed-Price Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs, Network Contracting Office 22, for the procurement of EPOC Prescott and RapidPoint 500 and 500e blood gas analyzers along with associated reagents, standards, controls, and maintenance services. The base performance period begins June 1, 2026, and includes four one-year option periods, creating a potential total contract duration of five years. Delivery is FOB destination to VA healthcare facilities in Long Beach, CA, Phoenix, AZ, and Tucson, AZ, with the contract administration office located in Long Beach. Award will be made on a Lowest Price Technically Acceptable (LPTA) basis, where price is the sole evaluation factor, and technical acceptability is determined solely through compliance with mandatory requirements and contractor responsibility. All pricing details are to be submitted by offerors, as the solicitation does not pre-populate unit or extended prices in the CLIN structure. Contractual obligations are governed by a comprehensive set of Federal Acquisition Regulation (FAR) and Veterans Affairs Acquisition Regulation (VAAR) clauses, including FAR 52.212-4 and 52.212-5 for commercial item contracting, FAR 52.216-21 for requirements-type contracting, and multiple labor standards clauses enforcing fair wages and contractor reporting under the Service Contract Act and Fair Labor Standards Act. Special requirements prohibit the use of covered telecommunications equipment from entities such as Huawei or ZTE, restrict contracting with inverted domestic corporations, and enforce compliance with OFAC sanctions and federal whistleblower protections. Invoicing must be submitted electronically through VA’s Electronic Invoice Presentment and Payment System (EIPPS) using X12 EDI formats, with no tolerance for fax, email, or scanned submissions. Packaging and labeling must adhere to VAAR 852.247-73 for domestic shipments, with expiration dates clearly marked on all reagents and controls, and use of the Martel Label Roll specified for consumable labeling. Offerors must maintain an active SAM registration, report executive compensation, and complete all representations and certifications per FAR 52.212-3, including UEI and CAGE disclosures, size status certifications, and affirmative disclosures regarding prohibited equipment or ownership structures. Proposals are due by May